SURMOUNT 1-4 post hoc analysis: weight and waist circumference in people with different durations of overweight or obesity
In this medfyle
A post hoc analysis of SURMOUNT-1 to -4 was presented at ECO 2024, showing that across the trials tirzepatide reduced body weight and waist circumference in people with overweight or obesity regardless of disease duration.
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
About this Medfyle
©2024 Medfyle. All rights reserved.
Source: Muscogiuri G, Pedersen SD, Jaouimaa F, et al. Tirzepatide reduced body weight and waist circumference in people with overweight or obesity regardless of disease duration: post hoc analysis of the SURMOUNT 1-4 trials. Obes Facts 2024;17(suppl 1):AS12.03.
The information and data provided is for information purposes only. The author(s) of the original original presentation had no involvement in the creation of this content.
